1,756
Participants
Start Date
September 11, 2018
Primary Completion Date
February 4, 2019
Study Completion Date
February 4, 2019
Nitazoxanide
Nitazoxanide 600 mg administered orally twice daily for five days
Placebo
Placebo administered orally twice daily for five days
Vanguard Study Site, Brooklyn
Vanguard Study Site, Baltimore
Vanguard Study Site, Raleigh
Vanguard Study Site, Stockbridge
Vanguard Study Site, Orlando
Vanguard Study Site, Miami
Vanguard Study Site, Miami
Vanguard Study Site, Miami
Vanguard Study Site, Tampa
Vanguard Study Site, Pelham
Vanguard Study Site, Birmingham
Vanguard Study Site, Birmingham
Vanguard Study Site, Jackson
Vanguard Study Site, Milan
Vanguard Study Site, Louisville
Vanguard Study Site, Columbus
Vanguard Study Site, Cleveland
Vanguard Study Site, Cincinnati
Vanguard Study Site, Dayton
Vanguard Study Site, Valparaiso
Vanguard Study Site, Missoula
Vanguard Study Site, Evanston
Vanguard Study Site, St Louis
Vanguard Study Site, Bellevue
Vanguard Study Site, New Orleans
Vanguard Study Site, New Orleans
Vanguard Study Site, Hot Springs
Vanguard Study Site, Carrollton
Vanguard Study Site, Plano
Vanguard Study Site, Houston
Vanguard Study Site, McAllen
Vanguard Study Site, Austin
Vanguard Study Site, Blackfoot
Vanguard Study Site, Meridian
Vanguard Study Site, Nampa
Vanguard Study Site, Bountiful
Vanguard Study Site, St. George
Vanguard Study Site, Las Vegas
Vanguard Study Site, Wilmington
Vanguard Study Site, Westminster
Vanguard Study Site, Anaheim
Vanguard Study Site, Medford
Vanguard Study Site, East Providence
Vanguard Study Site, Ponce
Vanguard Study Site, San Juan
Romark Laboratories L.C.
INDUSTRY